Pharmacological Intervention to Modulate HDL: What Do We Target?
The cholesterol concentrations of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) have traditionally served as risk factors for cardiovascular disease. As such, novel therapeutic interventions aiming to raise HDL cholesterol have been tested in the clinical setting. However, most tr...
Main Authors: | Nicholas J. Woudberg, Sarah Pedretti, Sandrine Lecour, Rainer Schulz, Nicolas Vuilleumier, Richard W. James, Miguel A. Frias |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00989/full |
Similar Items
-
Obesity Affects HDL Metabolism, Composition and Subclass Distribution
by: Julia T. Stadler, et al.
Published: (2021-02-01) -
Preeclampsia Affects Lipid Metabolism and HDL Function in Mothers and Their Offspring
by: Julia T. Stadler, et al.
Published: (2023-03-01) -
The Association of HDL2b with Metabolic Syndrome Among Normal HDL-C Populations in Southern China
by: Chen T, et al.
Published: (2024-01-01) -
Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
by: Leonie Schoch, et al.
Published: (2021-07-01) -
The metabolism and anti-atherogenic properties of HDL
by: Kerry-Anne Rye, et al.
Published: (2009-01-01)